Cellebrite DI Ltd.
CLBT
$13.18
$0.010.08%
NASDAQ
| 12/31/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | ||
|---|---|---|---|---|---|
| Revenue | 18.13% | 18.35% | 20.06% | 17.24% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 18.13% | 18.35% | 20.06% | 17.24% | |
| Cost of Revenue | 11.72% | 8.71% | 31.86% | 18.17% | |
| Gross Profit | 19.37% | 20.32% | 18.00% | 17.06% | |
| SG&A Expenses | 16.69% | 16.63% | 15.13% | 21.17% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 15.74% | 16.26% | 18.60% | 19.62% | |
| Operating Income | 32.31% | 32.27% | 32.67% | 4.84% | |
| Income Before Tax | 32.03% | 194.44% | 127.88% | 261.17% | |
| Income Tax Expenses | 697.77% | -26.78% | -5.63% | -72.72% | |
| Earnings from Continuing Operations | 10.34% | 181.79% | 124.38% | 231.56% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | 10.34% | 181.79% | 124.38% | 231.56% | |
| EBIT | 32.31% | 32.27% | 32.67% | 4.84% | |
| EBITDA | 34.10% | 26.86% | 24.92% | 4.77% | |
| EPS Basic | 2.42% | 167.67% | 120.22% | 209.69% | |
| Normalized Basic EPS | 25.52% | 185.98% | -- | 234.26% | |
| EPS Diluted | 1.78% | 166.17% | 119.31% | 197.16% | |
| Normalized Diluted EPS | 29.82% | 183.09% | -- | 226.70% | |
| Average Basic Shares Outstanding | 5.16% | 20.81% | 20.54% | 19.96% | |
| Average Diluted Shares Outstanding | 1.68% | 25.15% | 26.66% | 27.21% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |